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Abstract
Background: Tat-mediated activation of the HIV-1 promoter depends upon a proteasome-associated factor, PAAF1,
which dissociates 26S proteasome to produce 19S RP that is essential for transcriptional elongation. The effect of
PAAF1 on proteasome activity could also potentially shield certain factors from proteolysis, which may be
implicated in the transcriptional co-activator activity of PAAF1 towards the LTR.
Results: Here, we show that Spt6 is targeted by proteasome in the absence of PAAF1. PAAF1 interacts with the N-
terminus of Spt6, suggesting that PAAF1 protects Spt6 from proteolysis. Depletion of either PAAF1 or Spt6 reduced
histone occupancy at the HIV-1 promoter, and induced the synthesis of aberrant transcripts. Ectopic Spt6
expression or treatment with proteasome inhibitor partially rescued the transcription defect associated with loss of
PAAF1. Transcriptional profiling followed by ChIP identified a subset of cellular genes that are regulated in a similar
fashion to HIV-1 by Spt6 and/or PAAF1, including many that are involved in cancer, such as BRCA1 and BARD1.
Conclusion: These results show that intracellular levels of Spt6 are fine-tuned by PAAF1 and proteasome, which is
required for HIV-1 transcription and extends to cellular genes implicated in cancer.
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Background
Spt6 is a highly conserved transcription factor that plays
a number of distinct roles during transcription. It inter-
acts directly with histones, particularly H3, and pos-
sesses nucleosome assembly activity in vitro [1].
Together with FACT, a H2A/H2B chaperone, Spt6
restores chromatin structur ei nt h ew a k eo fe l o n g a t i n g
RNAPII [2,3]. Loss of Spt6 disrupts normal chromatin
structure and leads to the initiation of cryptic transcripts
from within the coding region [3]. At inducible genes,
Spt6 is required to restore transcriptional repression by
promoting nucleosome reassembly over the promoter
region [4,5]. Spt6 is a transcription elongation factor
that is associated with the body of genes during tran-
scription [6,7] and enhances the elongation rate of
RNAPII, even on naked DNA [8,9]. It contains tandem
SH2 domains that interact with phosphorylated Ser2
and Ser5 of the carboxy-terminal domain (CTD) of
RNAPII [10,11]. Spt6 is also implicated in mRNA pro-
cessing through interactions with the nuclear exosome
subunit, Rrp6, and Iws1 that recruits RNA processing/
export factors Ref1/Aly [11,12], and prevents premature
3’ processing at cryptic, upstream polyadenylation sites
[6]. Spt6 controls basal and Tat-mediated transcription
from the HIV-1 promoter [13,14] and controls HIV-1
latency [15]. Thus, Spt6 is required for transcription
through chromatin by ensuring proper nucleosome reas-
sembly during elongation and linking transcription to
mRNA processing and quality control.
26S proteasome, the major pathway of degradation for
ubiquitinated proteins in cells, consists of two large sub-
complexes, 19S regulatory particle (19S RP) and 20S
core particle (20S CP) [16]. 19S RP recognizes polyubi-
quitinated substrates that are subsequently degraded by
the 20S catalytic particle (20S CP) in an energy-depen-
dent manner. Previous studies have highlighted a role
for proteasome in controlling transcription [17]. Tran-
scription-coupled proteolytic destruction of activators
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Other studies, by contrast, suggest that 19S RP posi-
tively affects transcription through mechanisms that are
independent of proteolysis but may require the ATPase-
dependent chaperonin activity of 19S RP [19-21].
Indeed, proteolytic activity is excluded from regions that
are highly transcribed, but can become associated with
such regions under conditions that lead to transcrip-
tional stalling [22]. Alternatively, the degradation of
transcription factors can be more specifically controlled
in several ways. Most simply, the ubiquitinated lysine
residue can also be an acceptor residue for acetylation.
Thus, factor degradation is controlled via cycles of acet-
ylation/deacetylation, as shown for Foxo3 and RelA
[23,24]. In other cases, interaction with another factor
can control the rate of substrate degradation. For exam-
ple, interaction with FANCJ prevents proteolytic degra-
dation of Blm [25]. Similarly, HSP70 protects ATF5
from rapid degradation by proteosome in glioma cells
[26]. Thus, the proteolytic degradation of certain factors
can be specifically and reversibly controlled, which has
important implications for a number of cellular pro-
cesses, including transcription.
We have previously demonstrated that transcription
from the HIV-1 promoter is controlled by proteasome
[27]. In the absence of the viral transactivator, Tat, 26S
proteasome is associated with the promoter and
represses basal transcription. In the presence of Tat,
however, 19S RP is recruited to the HIV-1 promoter
where it facilitates an early step in transcriptional elon-
gation in a non-proteolytic manner. This switch is
dependent on a proteasomal ATPase-associated factor,
PAAF1. Originally identified through its binding to a
19S RP subunit, PAAF1 was shown to regulate protea-
some assembly and activity [27,28]. PAAF1 and its yeast
homologue, Rpn14, were subsequently characterized as
19S RP chaperones [29,30]. Since PAAF1/Rpn14 associ-
ates with the fully assembled base of 19S ATPases, but
dissociates prior to association of 20S CP, it is not
detected in association with 26S proteasome [28,31].
PAAF1 is physically associated with HIV-1 chromatin
and regulates 26S proteasome dynamics to produce 19S
RP that is essential for transcriptional elongation in the
presence of Tat [27,28]. Since both 19S RP and 20S CP
a r ep r e s e n to nt h eH I V - 1p r o m o t e ri nt h ea b s e n c eo f
PAAF1, it seems likely that promoter-associated protea-
some activity is enhanced under these conditions [27].
This raises the possibility that PAAF1 might shield cer-
tain factors from proteasomal degradation, which could
have consequences for HIV-1 transcription. Here, we
show that PAAF1 specifically protects Spt6 from protea-
somal degradation, which is crucial for nucleosome
assembly during transcription at the HIV-1 promoter.
Since regulation of the LTR is often a paradigm for
cellular genes, we wondered if this mechanism operating
at the LTR extends to cellular genes. Transcriptional
profiling in either PAAF1 or Spt6 knockdown cells fol-
lowed by ChIP analysis at selected genes revealed an
important role for Spt6 and PAAF1 in controlling the
expression of a subset of genes involved in cancer.
Results
Spt6 level is modulated by PAAF1 in proteasome
dependent-manner
PAAF1 is a modulator of proteasome [27,28] and 19S
RP chaperone [29,29-31]. We have previously shown
that PAAF1 enhances HIV-1 transcription through its
ability to generate free 19S RP that facilitates transcrip-
tional elongation [27]. To address whether the 19S cha-
perone function of PAAF1 might play an additional role
in transcription by protecting certain factors from pro-
teasomal degradation, we sought to identify factor(s)
important for HIV-1 transcription whose stability is
dependent on PAAF1. Following RNA interference
(RNAi) against PAAF1 or a non-specific control (scr), a
number of transcription factors were analyzed by IB to
identify those diminished by loss of PAAF1. Among
those analyzed, only Spt6 was significantly reduced in
PAAF1 RNAi cells. Subunits of RNAPII, P-TEFb, PAF1
and NELF complexes, among others, were not affected
(Figure 1A and Additional file 1, Figure S1A). In addi-
tion, PAAF1 did not affect the level of several known
proteasome substrates (Additional file 1, Figure S1B)
suggesting that the effect on Spt6 is not due to global
deregulation of proteasome. While Spt6 protein was
diminished in PAAF1 RNAi cells, no effect was observed
on Spt6 mRNA as measured by RT-Q-PCR (Additional
file 2, Figure S2), indicating that PAAF1-mediated mod-
ulation of Spt6 occurs post-transcriptionally. Next, to
determine whether Spt6 is degraded by proteasome, we
analyzed Spt6 levels in cells treated for 8 h with or with-
out proteasome inhibitor, MG132, in the presence or
absence of PAAF1. Accumulation of p53 in MG132-
treated cells shows that proteasome was efficiently
inhibited (Figure 1B). Diminution of Spt6 in PAAF1
RNAi cells was partially restored by treatment with
MG132 (Figure 1B). These data suggest that PAAF1
protects Spt6 from proteasomal degradation, and modu-
lates the intracellular level of Spt6 protein.
We then asked whether diminution of Spt6 following
PAAF1 depletion might affect Spt6 recruitment to chro-
matin. Control or PAAF1 RNAi cells containing a stably
integrated LTR linked to a Luciferase reporter (HeLa-
LTR-luc) were analyzed by chromatin immunoprecipita-
tion (ChIP) to detect Spt6 association with the HIV-1
promoter and luciferase region. Spt6 association was
reduced to almost the same extent by PAAF1 RNAi as
by Spt6 RNAi (Figure 1C). In contrast, Spt6 recruitment
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might be restricted to specific genes (Additional file 3,
Figure S3). Since the Spt6 level in cell extract was par-
tially recovered by MG132, we asked if Spt6 recruitment
to the LTR was also rescued. MG132 treatment signifi-
cantly enhanced Spt6 association with HIV-1 chromatin
in PAAF1 RNAi cells but had no effect in control cells
(Figure 1D). These data suggest that PAAF1 stabilizes
Spt6 to levels that are sufficient for its association with
HIV-1 chromatin.
PAAF1 physically interacts with Spt6
Since PAAF1 modulated Spt6 levels without affecting
other factors, we tested whether these two proteins
interact. Extracts from 293T cells expressing Flag-
PAAF1 alone or together with Myc-Spt6 were used for
co-immunoprecipitation analysis. Flag-PAAF1 was
immunoprecipitated by anti-Myc antibody but not con-
trol IgG (Figure 2A, left panel). Similarly, Myc-Spt6 was
immunoprecipitated by anti-Flag antibody (Figure 2A,
right panel). Furthermore, an interaction between endo-
genous Spt6 and PAAF1 could also be detected in 293T
extract (Figure 2B). To identify the region of Spt6 that
binds to PAAF1, full-length and mutant Myc-Spt6 were
transiently expressed in 293T cells and analyzed for
associated PAAF1 by IB (Figure 2C). PAAF1 bound to
the N-terminal (1-916) fragment of Spt6, but did not
recognize its C-terminal fragment (1162-1726) that
interacts with RNAPII [11]. Thus, PAAF1 specifically
interacts with the N-terminal region of Spt6. We then
asked whether these factors localize to sites of HIV-1
transcription. Transcripts emanating from the HIV-1
LTR were visualized using U2OS cells in which an LTR,
which is linked to a reporter containing binding sites for
MS2 protein, is stably integrated (U2OS-LTR-MS2) [32].
Following activation of HIV-1 by Tat, HIV-1 transcrip-
tion foci are marked by an accumulation of MS2-cherry
bound to its cognate binding sites present in the HIV-1
transcript (Figure 3A); elongating RNAPII that is phos-
phorylated on Ser2 of the CTD localized with the site of
HIV-1 transcription. Spt6 similarly localized with HIV-1
transcription foci. Staining of endogenous PAAF1
revealed a diffuse nucleoplasmic pattern as well as sev-
eral nuclear foyers. A PAAF1-containing foyer localized
with the HIV-1 transcription site in the majority of cells
examined. The specificity of the anti-PAAF1 antibody
was validated in PAAF1 knockdown cells (Figure 3B).
Thus, PAAF1, Spt6 and elongating RNAPII localize to
sites of HIV-1 transcription.
PAAF1-mediated Stabilization of Spt6 Facilitates
Nucleosome Reassembly during Transcription
Spt6 is a histone chaperone that helps to restore chro-
matin structure during transcription [2,3]. Thus, control,
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Figure 1 Spt6 levels are controlled by PAAF1 in a proteasome-dependent manner. (A) HeLa cells transfected with siRNA against PAAF1 or
a control (Scr) were analyzed by IB using the indicated antibodies. (B) Extracts from HeLa transfected with the indicated siRNAs and treated with
MG132 where indicated were analyzed by IB using the indicated antibodies. (C) Spt6 association with HIV-1 chromatin is diminished by ablation
of PAAF1. HeLa-LTR-luc transfected with the indicated siRNAs were analyzed by IB using the indicated antibodies, and ChIP using anti-Spt6.
Sequences within the HIV promoter and luciferase region were amplified by Q-PCR. The value for the Scr sample in the promoter region was set
to 1. Locations of primers used for PCR amplification are indicated above the graph. (D) Cells in B were analyzed by ChIP as described in C using
anti-Spt6. Graphs show mean +/- SD (n = 3).
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Page 3 of 11Spt6 and PAAF1 knockdown cells were analyzed by
ChIP for the association of histones H3 and H2B. Global
levels of histones present in cell extract were not
affected by the knock-downs (Figure 4A). However,
both H3 and H2B were significantly diminished at the
HIV-1 promoter (prom) and luciferase region by either
PAAF1 or Spt6 RNAi (Figure 4B). In contrast, no effect
on histone occupancy was observed at the GAPDH pro-
moter region (Additional file 4, Figure S4). These results
suggest that PAAF1 and Spt6 are required for histone
reassembly at HIV-1 chromatin, but appear to be dis-
pensable at other regions, such as GAPDH.T h e
observed histone loss led us to analyze the recruitment
of RNAPII to the HIV-1 promoter in PAAF1 and Spt6
knockdown cells. RNAPII association with the LTR and
coding region was significantly enhanced in PAAF1 and
Spt6 knockdown cells compared to controls (Figure 4B).
Recruitment of PAF1, which associates with elongating
RNAPII [33], mirrored thato fR N A P I Ii nP A A F 1a n d
Spt6 knockdown cells (Figure 4B). Levels of RNAPII or
PAF1 in cell extract were not significantly altered by
knock down of either PAAF1 or Spt6 (Figure 4A).
These data suggest that loss of PAAF1 destabilizes Spt6,
which disrupts nucleosome reassembly at HIV-1 chro-
matin. Proteasome inhibition in PAAF1 knockdown
cells partially recovered levels of Spt6 in cell extract
(Figure 1B) and increased its association with HIV-1
chromatin (Figure 1D). The same samples were then
used to address the role of PAAF1 and proteasome on
nucleosome assembly through the stabilization of Spt6.
Occupancy of H3 and H2B at HIV-1 chromatin was
partially restored in PAAF1 knockdown cells following
treatment with MG132 (Figure 4C) but was not affected
in control cells. We have previously shown that MG132
increases transcriptional output from the HIV-1 promo-
ter [27]. Consistent with this, RNAPII association with
HIV-1 chromatin increased in control cells following
MG132 treatment, in a PAAF1-independent manner
(Figure 4C). While PAAF1 knockdown also enhanced
RNAPII recruitment, as observed in Figure 4B, treat-
ment of these cells with MG132 reset RNAPII levels
closer to those in control cells (Figure 4C). Thus,
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Figure 2 PAAF1 interacts with the N-terminus of Spt6. (A) Extracts from 293T transfected with PAAF1-Flag alone or together with Myc-Spt6
were analyzed by IP-IB using the indicated antibodies. (B) 293T extract was immunoprecipitated using anti-Spt6 followed by IB using anti-PAAF1.
(C) Extracts from 293T transfected with PAAF1-Flag and the indicated Spt6-Myc constructs were immunoprecipitated using anti-Myc or IgG
followed by IB with anti-Flag.
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levels and reversed the phenotype associated with loss
of PAAF1. These data suggest that PAAF1-mediated
modulation of proteasome activity stabilizes Spt6 and is
required for nucleosome reassembly at the HIV-1
promoter.
PAAF1-dependent stabilization of Spt6 is required to
suppress aberrant HIV-1 transcription
Disruption of chromatin structure following loss of Spt6
function facilitates the initiation of cryptic transcripts
from within the coding region [3]. Furthermore, loss of
nucleosome reassembly in Spt6 mutant strains has been
shown to increase PHO and CHA1 transcription in the
absence of transcriptional activator [4,5]. To investigate
the relevance of PAAF1-mediated protection of Spt6 in
HIV-1 transcription, we analyzed HIV-1 transcript synth-
esis following PAAF1 or Spt6 knockdown. In control
cells transduced with the HIV-1 transactivator, Tat, (Scr
+Tat), luciferase mRNA and corresponding Luciferase
activity was significantly increased (Figure 5A). PAAF1
knockdown cells showed a similar increase in transcript
synthesis from the LTR, even in the absence of Tat. How-
ever, Luciferase activity was much reduced compared to
Tat-treated samples. Like PAAF1 RNAi cells, loss of Spt6
increased transcript abundance similarly to Tat treat-
ment, whereas Luciferase activity was relatively low (Fig-
ure 5A). A similar increase in transcripts in the absence
of activator was also detected using U2OS-LTR-MS2
cells following loss of PAAF1 (Additional file 5, Figure
S5). Neither PAAF1 nor Spt6 knockdown significantly
affected GAPDH transcript abundance (data not shown).
A 
B 
Figure 3 Spt6, PAAF1 and RNAPII localize at sites of HIV-1 transcription. (A) U2OS-LTR-MS2 cells transfected with pMS2-cherry and pTat-
Flag were fixed, and analyzed by immunofluorescence using the indicated antibodies. Sites of co-localization with MS2-labelled HIV-1
transcription sites are indicated by arrowheads. (B) Anti-PAAF1 antibody specifically recognizes endogenous PAAF1. U2OS-LTR-MS2 cells were
transfected with control (scr) or PAAF1-specific siRNA, and fixed 48 hr later. Cells were pre-treated with 0.05% Triton/PBS, fixed and stained with
anti-PAAF1 antibody (red) for immunofluorescence analysis.
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Page 5 of 11The uncoupling of HIV-1 transcript synthesis and
protein production in PAAF1 and Spt6 knockdown cells
suggests that, although transcription is increased, the
transcripts may be aberrant. RT-Q-PCR analysis was
thus performed in the case of PAAF1 RNAi using pri-
mer pairs spanning the transcript (Figure 5B). Amounts
of transcripts were normalized to the value obtained in
the TAR region, a RNA hairpin located at the 5’ end of
initiated HIV-1 transcripts, in order to assess the
efficiency of transcription elongation. In the absence of
Tat (siScr + GST), transcripts were poorly elongated
since more transcripts contained TAR than luc 3’
sequences. As expected, transcripts were efficiently elon-
gated in the presence of Tat since equivalent amounts
of TAR and products up to the 3’ end of luciferase
could be detected. In PAAF1 knockdown cells, by con-
trast, transcripts were poorly elongated, in both the pre-
sence and absence of Tat (Figure 5B). Additionally,
transcripts that were elongated up to the 3’ end of luci-
ferase were presumably incompetent for protein synth-
esis, which may be in part due to the function of Spt6
in mRNA 3’ processing [6,7] export [11]. Thus, tran-
scripts synthesized in the absence of PAAF1 are aber-
rant, likely due to a combination of defects in
elongation and RNA processing/export. We next asked
whether the transcriptional defect in PAAF1 knockdown
cells could be suppressed by Spt6. Ectopic expression of
Spt6 had no effect on HIV-1 transcription in control
cells (Figure 5C). In contrast, expression of HA-Spt6
partially reversed the increase in transcription induced
following loss of PAAF1. Taken together, these data
show that Spt6 is required for repression of basal tran-
scription, and loss of Spt6 following PAAF1 knockdown
permits aberrant transcription that is highly inefficient
for protein synthesis.
Regulation of Cellular Genes by PAAF1 and/or Spt6
We next wished to determine whether PAAF1 and/or
Spt6 regulate cellular genes in a similar fashion to the
HIV-1 LTR. Thus, transcriptional profiling was per-
formed using mRNA isolated from control, PAAF1 or
Spt6 knock-down cells. When compared to the control
sample, PAAF1 knockdown deregulated a specific subset
of genes, of which more than 50% (210/370) were also
deregulated by Spt6 knockdown (Figure 6A,Additional
file 6, Figure S6A). This suggests that modulation of
Spt6 protein level is probably a major function of
PAAF1. Spt6 RNAi led to deregulation of a much larger
subset of genes. Consistent with this, although the
expression level of Spt6 was strongly diminished by
siRNA against PAAF1, it is more severely reduced by
Spt6-specific RNAi, as might be expected (Figure 6A).
Gene ontology analysis revealed that knockdown of Spt6
or PAAF1 impacted most strongly on genes involved in
cell growth and proliferation while Spt6 RNAi also
affected genes involved in cell cycle and DNA replica-
tion, recombination and repair (Figure 6B). Since such
genes are frequently deregulated in cancer, Ingenuity
Pathway analysis showed that knockdown of PAAF1 or,
more particularly, Spt6, impacted strongly on genes
involved in cancer (Figure 6B). A group of genes was
selected for further analysis. Spt6 association with
selected genes was analyzed by ChIP in control, PAAF1-
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Figure 4 Loss of PAAF1 or Spt6 leads to histone depletion and
recruitment of RNAPII at HIV-1 sequences. (A) HeLa-LTR-luc
transfected with siRNA against Spt6, PAAF1 or a control were
analyzed by IB using the indicated antibodies. (B) Cells in A were
analyzed by ChIP using the indicated antibodies on the HIV
promoter (prom) and luciferase region (coding) as indicated. The
value for the Scr sample in the promoter region was set to 1. (C)
HeLa-LTR-luc transfected with Scr or PAAF1 siRNA, followed by
treatment with MG132 as indicated, were analyzed by IB and ChIP
using the indicated antibodies. Sequences within the HIV-1
promoter and luciferase regions were amplified by Q-PCR. Values
obtained for siScr samples in the promoter region were set to 1.
Graphs show mean +/- SD (n = 3).
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Page 6 of 11and Spt6 knockdown cells. Spt6 was enriched between 4
and 15-fold compared to a mock IP at all genes tested
(Figure 6C). In Spt6 RNAi cells, its association was
reduced between 2 and 4 fold at all genes except PUM1.
In all cases, loss of Spt6 correlated with deregulation of
transcription. However, the outcome was not the same
at all genes examined. Transcript abundance was
increased for INHBA, NOV, MET and others, while it
decreased for genes including BRCA1, BARD1 and BLM
(Figure 6C). Interestingly, PAAF1 knockdown reduced
Spt6 association with some genes but not others. For
example, Spt6 associationw i t hI N H B A ,N O V ,T H S D 4 ,
MET or E2F1 was diminished to almost the same extent
in either PAAF1 or Spt6 knockdown cells (Figure 6C).
Consistently, the effect on transcript abundance for each
gene following PAAF1 or Spt6 knockdown was similar
(Figure 6C). Exceptions to this were SERPINE2 and
GDF15, which were enhanced by PAAF1 knockdown
even though Spt6 association was unaffected. This
group of genes was identified by transcriptional profiling
as being regulated by both Spt6 and PAAF1. On the
other hand, association of Spt6 with genes such as
BRCA1, BARD1, BLM, FANCA and TOP2A was dimin-
ished by knockdown of Spt6 but not PAAF1. Consis-
tently, transcript abundance was altered by RNAi
against Spt6 but not PAAF1. These genes were identi-
fied by transcriptional profiling as being regulated only
by Spt6. IB analysis of some of the factors analyzed by
ChIP and RT-Q-PCR showed that the effects on tran-
script level correlated well with protein level in Spt6
knockdown cells (Additional file 6, Figure S6B). In
PAAF1 knockdown cells, some effects on protein
expression could be observed that appear to be post-
transcriptional, for example for FANCA and TOP2A, in
which transcript abundance was not reduced but protein
level was nevertheless diminished. These effects may be
due in part to the effect of PAAF1 on 26S proteasome
activity that may alter the levels of factors that can be
degraded by proteasome. Overall, this analysis demon-
strates that Spt6 regulates the transcription of a number
of genes that have been linked to cancer. However, loss
of Spt6 produced different outcomes at different genes.
Transcript levels of several oncogenes such as NOV and
MET increased, while those corresponding to a number
of factors involved in DNA repair, such as BRCA1,
BARD1 and BLM, were diminished.
Discussion
We have previously demonstrated that PAAF1, a modu-
lator of proteasome activity, is required for HIV-1 tran-
scription [27]. In this study, we show that PAAF1
specifically protects Spt6, a key factor in nucleosome
reassembly, transcription elongation and RNA proces-
sing, from proteasomal degradation. PAAF1 interacts
with Spt6 and both factors localize at the HIV-1 promo-
ter. The level of Spt6 in cells, and also its association
with HIV-1 chromatin are modulated by PAAF1 in a
proteasome-dependent manner. Ablation of either
PAAF1 or Spt6 led to loss of histones from HIV-1 chro-
matin, concomitant association of RNAPII and the
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Page 7 of 11induction of transcripts that were largely defective for
protein synthesis.
As nucleosomes present a barrier to the passage of
RNAPII, many factors, including histone chaperones, are
required to coordinate their removal ahead of RNAPII,
and their redeposition in the wake of elongating RNAPII
[34]. The repositioning of nucleosomes can prevent
cryptic transcription that may have deleterious effects.
Loss of nucleosomes can deregulate transcription. For
example, depletion of histone H4 increased transcription
from a subset of genes in yeast [35], and reassembly of
nucleosomes is required to repress transcription under
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requires the concerted action of chaperones, Spt6 and
FACT, which interact with histones to restore chroma-
tin structure in the wake of RNAPII. Interestingly,
PAAF1 knockdown did not affect occupancy of the
Spt16 subunit of FACT at HIV-1 chromatin suggesting
that, while PAAF1 regulates Spt6, Spt16 is not subject
to the same regulatory mechanism even though both
chaperones frequently function at the same genes. Our
findings indicate that modulation of Spt6 by PAAF1 and
proteasome controls transcription at the HIV-1 promo-
ter by facilitating the restoration of chromatin structure.
Transcriptional profiling following PAAF1 or Spt6
RNAi showed that, among genes that are deregulated by
PAAF1 knockdown, more than 50% were also deregu-
lated following Spt6 knockdown. Since the involvement
of PAAF1 in transcription is not as widespread as Spt6,
it suggests that additional factors may determine which
of the Spt6-regulated genes are also regulated by
PAAF1. Genes that are commonly deregulated may be
those that are highly sensitive to reduced levels of Spt6
in cells. Gene ontology analysis revealed that many of
the differentially expressed genes following either
PAAF1 or Spt6 knockdown are implicated in cancer.
Among the genes deregulated PAAF1 or Spt6 RNAi
cells were several oncogenes, such as NOV and MET,
whose expression was increased. In contrast, a subset of
genes including tumor suppressors, such as BRCA1,
BARD1 and BLM, were highly deregulated by loss of
Spt6 but were only modestly affected or unaffected by
loss of PAAF1, even though Spt6 level in these cells was
significantly diminished. Since Spt6 is associated with all
of the genes analyzed, the results suggest that certain
genes, such as INHBA, NOV and MET may be highly
sensitive to loss of Spt6, whereas others such as BLM,
FANCA and TOP2A, may be more resistant to loss of
Spt6 and can tolerate modest reductions in Spt6 expres-
sion levels. Thus, Spt6 appears to control the expression
of a number of genes, including several that are involved
in cancer.
Conclusion
We show that the HIV-1 transcriptional coactivator,
PAAF1, specifically protects Spt6, a key factor in nucleo-
some reassembly, transcription elongation and RNA
processing, from proteasomal degradation, and is thus
required for transcription from the HIV-1 LTR.
Methods
Cell culture, antibodies and plasmids
HeLa-LTR-luc cells that contain luciferase under the
control of an integrated HIV-1 LTR were obtained from
K.-T. Jeang (NIAID, NIH, USA) and propagated in Dul-
becco’s modified Eagle’s medium (DMEM, Lonza)
supplemented with 10% FBS and antibiotics. The cells
were treated with MG132 (Sigma) for 8 h, where indi-
cated. U2OS cells containing a stably integrated HIV-1
LTR linked a reporter containing binding sites for MS2
protein [32] were obtained from E. Bertrand (IGMM,
Montpellier) and propagated in DMEM supplemented
with 10% FBS and antibiotics. Antibody recognizing
human PAAF1 was raised in rabbits against an immuno-
genic peptide (Abnova). Antibodies used were anti
CDK9, p53, NOV, BARD1 and BLM (SCBT), RNAPII,
H3, H2B, Spt6, PAF1 and TOP2A (Abcam), Spt6 for IP
(Bethyl Laboratories), Tubulin and Flag M2 (Sigma).
pcDNA3-Flag-Spt6-HA [9] and pMyc-Spt6 [11] were
gifts from H. Handa and K.A. Jones, respectively. pTat-
Flag has been described previously [27].
RNAi and transfection experiments
HeLa LTR-Luc cells were transfected using Interferin
(PolyPlus Transfection) with 5 nM double-stranded siR-
NAs following the manufacturer’s instructions. At 48 hr
after transfection, cells were treated with GST or GST-
Tat as previously described [32]. Luciferase activity was
measured 48 hr after transduction according to the
manufacturer’s protocol (Promega). Luciferase activity
was normalized to protein concentration using Bradford
(BioRad). Double stranded RNA oligonucleotides direc-
ted against target sequences in PAAF1 (AGC CUG
UUC UCU GGA GGA A) [27], Spt6 (GAA GCC UCA
UGU AGU GAC A), Cdk9 (CUA GGG CUC UUG
UGU UUU U), and a control siRNA (Scrambled) [27]
were purchased from Eurofins MWG Operon.
Microarray Experiments
HeLa cells were transfected with 5 nM of a control
siRNA (Ambion #1 Silencer select), or siRNAs targeting
PAAF1 or Spt6 (modified by Silencer, Ambion). To pre-
pare samples, total RNAs were extracted using Trizol
(Invitrogen) and quantified by nanodrop spectrophoto-
metry. RNA quality was evaluated using the Agilent
Bioanalyzer 2100 and Lab-on-Chip Nano 6000 chip
(ratio of the 28S/18S RNA ≥ 1.5). RNA samples from
knockdown experiments were labeled with Cy3 dye
using the low RNA input QuickAmp kit (Agilent) as
recommended by the supplier. 825 ng of labeled cRNA
probe were hybridized on a 8x60K high density Sure-
Print G3 gene expression human Agilent microarray.
Two biological replicates were performed for each com-
parison. The experimental data have been deposited in
the NCBI Gene Expression Omnibus (GEO) (http://
www.ncbi.nlm.nih.gov/geo/) under series record
GSE32033. Normalization was performed using the
Limma package available from Bioconductor (http://
www.bioconductor.org). Inter-slide normalization was
performed using the quantile methods. Means of ratios
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was performed. Ontologies attached to each modulated
gene were then used to classify them according to main
biological themes using Ingenuity software (http://www.
ingenuity.com/).
RT-Q-PCR
Total RNA was extracted from HeLa LTR-luc cells
using Trizol (Invitrogen) and reverse-transcribed using
Superscript First-strand Synthesis System for RT-PCR
(Invitrogen). RT products were amplified by quantitative
PCR on a LightCycler LC480 (Roche) by using the oli-
gonucleotides shown in Additional file 7, Table S1.
TAR, early, luc and luc 3’ and GAPDH primers have
been described previously [27,32]. Q-PCR cycling condi-
tions are available on request.
Chromatin immunoprecipitation (ChIP)
HeLa-LTR-Luc cells were treated for 4 hr with DMEM
containing 100 μM chloroquin (Sigma), and 2 mg/ml of
GST or GST-Tat. ChIP analysis was performed as
described previously [27], except using Dynabeads A or
G (Invitrogen) for immunoprecipitation. Normal IgA or
IgG (SCBT) was used as a negative control (mock sam-
ple). Quantification of immunoprecipitated material was
performed by quantitative PCR using LightCycler LC480
(Roche) and normalized for input DNA. Sequences of
oligonucleotide primers are shown in Table S1. LTR
prom and coding primers have been described pre-
viously [27,32]. Primers were mixed with Quanti Tect
Sybr Green (Qiagen), Biorad SYBR green (BioRad) or
LightCycler LC480 SYBR Green I Master (Roche). Q-
PCR cycling conditions are available on request.
Results were calculated as follows: the value obtained
using the specific antibody, expressed as a percentage of
input DNA, was divided by the value obtained for the
mock IgA or IgG sample. The value obtained for the
control sample, usually siScr, was set to 1. The test sam-
ples were expressed as a ratio of the control.
MS2 Immunofluorescence
U2OS cells containing the HIV-LTR fused to 24 bac-
teriophage MS2-binding sites [36] were plated on cov-
erslips and transfected with siRNA using
Oligofectamine (Invitrogen). After 24 h, cells were
transfected with vectors expressing Tat and MS2-GFP
using Lipofectamine2000 (Invitrogen). For single MS2
staining, cells were washed once with PBS, and fixed
with 4% paraformaldehyde (PFA, Sigma) for 20 min at
room temperature, followed by DNA staining using
Hoechst (Sigma). For immunofluorescence, cells were
pre-permeabilized with 0.05% Triton-X-100 (Sigma)
prior to fixation with 2 or 4% PFA for 5 min on ice.
After a PBS wash, coverslips were incubated with
blocking buffer (5% bovine serum albumin (BSA)/PBS)
for 1 h at room temperature. Blocking buffer contain-
ing primary antibodies was overlaid onto a coverslip
and incubated for 1 h at room temperature. After
washing three times with PBS, cells were treated with
secondary antibodies conjugated with Alexa488 or Cy5
(Invitrogen) in blocking buffer for 1 h at room tem-
perature. After 3 PBS washes, samples were counter-
stained for DNA. Fluorescent images of fixed cells
were imaged on a Leica DM 6000-1 microscope (Leica)
using MetaMorph software (Molecular Devices).
Additional material
Additional file 1: Figure S1. PAAF1 knock-down does not affect known
proteasome substrates or transcription factors other than Spt6. HeLa cells
were transfected with siRNA targeting a control (Scr) or PAAF1 (A),
followed by treatment with proteasome inhibitor, MG132 (MG), for 8 h
before harvesting, where indicated (B). Total cell extract was analyzed by
IB using the indicated antibodies.
Additional file 2: Figure S2. Spt6 levels are controlled by PAAF1 in a
proteasome-dependent manner. Total RNA was isolated from cells in
Figure 1A was analyzed by RT-Q-PCR using Spt6-specific primers. Values
were normalized to the quantity of GAPDH mRNA in each sample, and
the value for the control sample (scr) was set to 1.
Additional file 3: Figure S3. Association of Spt6 with the GAPDH
promoter is not diminished by ablation of PAAF1. HeLa-LTR-luc cells
transfected with the indicated siRNAs were harvested and analyzed by
ChIP using anti-Spt6. A sequence within the GAPDH promoter was
amplified by Q-PCR. The value for the control (Scr) sample was set to 1.
Graph represents mean +/- SD obtained from at least 3 independent
experiments.
Additional file 4: Figure S4. Association of H2B and H3 with the
GAPDH promoter is not diminished by ablation of PAAF1. HeLa-LTR-luc
cells transfected with the indicated siRNAs were harvested and analyzed
by ChIP using the indicated antibodies. A sequence within the GAPDH
promoter was amplified by Q-PCR. The value for the control (Scr) sample
was set to 1. Graphs represent mean +/- SD obtained from 3
independent experiments.
Additional file 5: Figure S5. Ablation of PAAF1 induces HIV-1
transcription. U2OS-LTR-MS2 cells were transfected with pMS2-cherry and
pTat-Flag where indicated, then fixed and analyzed by
immunofluorescence. Sites of MS2-labelled HIV-1 transcription sites are
indicated by arrowheads.
Additional file 6: Figure S6. Identification of cellular genes controlled
by Spt6 and/or PAAF1. (A) Heat map showing the differential regulation
of cellular genes following loss of PAAF1 or Spt6, as compared to a
negative control siRNA. Results from duplicate experiments are shown.
(B) Individual genes within the cancer pathway that were identified by
transcriptional profiling were analyzed by IB using the indicated
antibodies in HeLa cells transfected with control, PAAF1 or Spt6 siRNA.
Additional file 7: Table S1. Sequences of oligonucleotides pairs used
for q-PCR amplification.
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